when was semaglutide approved FDA-Approved Oral Semaglutide: The First GLP-1 Pill FDA Warns on Certain Forms

Side effects are similar to those seen with other GLP-1 receptor agonists and tend to decrease over time

Retatrutide Name: Retatrutide Manufacturer: Eli Lilly Current stage: Phase III results expected late 2025/2026 Takeaway: If licensed, it could be more effective for weight loss than other GLP-1s

A new nationally representative survey conducted by NORC at the University of Chicago reveals growing awareness of glucagon-like peptide-1 (GLP-1) medications, with many adults learning about the drugs by chance via social media, news, and family and friends

Take a reference photo of each new vial When you receive a new vial, photograph it immediately

Providers must review your complete medication list and may adjust dosing or timing

Specifically, in the group of patients prescribed semaglutide for weight loss, 6.7% developed NAION compared to just 0.8% of those on other treatments